Qingyan Hu

Title: Qingyan Hu: Innovator in Pharmaceutical Formulations

Introduction

Qingyan Hu is a prominent inventor based in Millwood, NY (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable antibody formulations. With a total of 3 patents, his work has the potential to impact therapeutic applications significantly.

Latest Patents

One of his latest patents is focused on a stable antibody formulation. This invention provides stable pharmaceutical formulations comprising a human antibody that specifically binds to the human programmed death-1 protein (PD-1). The formulations include a buffer, an amino acid, a non-ionic surfactant, and a sugar, ensuring a substantial degree of antibody stability upon stress and storage. Another notable patent involves stabilized formulations containing anti-IL-33 antibodies. This invention offers pharmaceutical formulations comprising an antibody that specifically binds to human interleukin-33 (hIL-33). These formulations also include a buffer, at least one amino acid, at least one sugar, or at least one non-ionic surfactant, demonstrating significant stability after storage and exposure to thermal and other physical stresses.

Career Highlights

Qingyan Hu is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to innovate in the field of biopharmaceuticals. His expertise in antibody formulations has positioned him as a key player in the development of new therapeutic solutions.

Collaborations

He collaborates with various professionals in his field, including his coworker Dingjiang Liu, to advance research and development efforts.

Conclusion

Qingyan Hu's contributions to stable antibody formulations highlight his role as an influential inventor in the pharmaceutical industry. His work not only enhances the stability of therapeutic antibodies but also paves the way for future innovations in drug formulation.